Skip to main content

Table 1 EE Studies by type of device assessed, purpose of device, EU risk class and targeted pediatric group. Medical Device Risk Classification according to the new EU Medical Device Regulation

From: Economic evaluations of medical devices in paediatrics: a systematic review and a quality appraisal of the literature

Author

(Publication Year)

Type of device assessed

Purpose of the device

Device EU risk class

Pediatric age group considered in the EE study

Aburahma S

(2015)

Vagus Nerve Stimulation device

Therapeutic

III

Infants, children and adolescents

Cheng A

(2000)

cochlear implant

Therapeutic

III

Infants and children

O’Neill C

(2000)

cochlear implant

Therapeutic

III

Infants and children

Carter R

(1999)

cochlear implant

Therapeutic

III

Infants and children

Barton G

(2006)

cochlear implant

Therapeutic

III

Infants and children

Foteff C

(2016)

cochlear implant

Therapeutic

III

Infants, children and adolescents

Schulze-Gattermann H

(2002)

cochlear implant

Therapeutic

III

infants and children

Summerfield A

(2010)

bilateral cochlear implant

Therapeutic

III

infants and children

Ahmadi A

(2013)

3 types of cardiac duct occluders

Therapeutic

III

Infants, children and adolescents

Brown K

(2009)

ECMO device (as a bridge to transplant)

Life-supporting/Therapeutic

IIb

Infants, children and adolescents

El-Saiedi S

(2017)

3 types of cardiac duct occluders

Therapeutic

III

infants and children

Heidari S

(2017)

auditory brainstem response device

Diagnostics

Iia

neonates

Petrou S

(2006)

ECMO

Life-supporting device

IIb

neonates

Mahle W

(2008)

Ventricular Assisting Device

Therapeutic

III

neonates, infants, children and adolescents

Campbell K

(2007)

Head Computed Tomography (CT)

Diagnostics

IIb

Infants

Chen A

(2014)

bubble CPAP device

Life-supporting/Therapeutic

IIb

Neonates

Huang L

(2018)

CPAP device

Life-supporting/Therapeutic

IIb

preterms

Santiago Medina L

(2001)

diagnostic imaging equipment (MRI, CT, XR)

Diagnostics

IIa and IIb

Neonates

von Keyserlingk K

(2011)

wrist splints

Therapeutic

I

infants and children

Santiago Medina L

(2002)

3D CT equipment

Diagnostics

IIb

infants and children

Saunders J

(2015)

cochlear implant

Therapeutic

III

infants and children

Emmet S

(2015)

cochlear implant

Therapeutic

III

infants and children

Pérez-Martin J

(2017)

bilateral cochlear implant

Therapeutic

III

Infants

Avanceña A

(2021)

implantable ventricular assisting device

Therapeutic

III

adolescents

Cheng L

(2019)

bilateral cochlear implant

Therapeutic

III

Infants, children and adolescents

Fang T

(2019)

unilateral cochlear implant + contralateral acoustic hearing aid

Diagnostics

Iia

Children and adolescents

Trujillo, D

(2019)

pulse oximeter

Life-supporting/Therapeutic

Iia

Neonates

Mowitz, M

(2017)

nasal continuous positive pressure device

Diagnostics

Iia

Neonates

Narayen, I

(2019)

pulse oximeter

Diagnostics

Iia

Neonates

Peterson, C

(2013)

pulse oximetry

Therapeutic

III

Neonates

Qiu, J

(2017)

cochlear implant

Diagnostics

Iia

Infants and children

Roberts, T

(2012)

pulse oximeter

Diagnostics

Iia

Neonates

Tobe, R

(2017)

pulse oximeter

Diagnostics

Iia

Neonates

Mukerji, A

(2020)

pulse oximeter

Life supporting/Therapeutic

III

Neonates

Evers, P

(2019)

The continuous-flow ventricular assist device

Life supporting/Therapeutic

III

children

Buendía, J.

(2021)

High-flow nasal cannula

Life supporting/Therapeutic

IIb

Infants, children and adolescents

Huang, L

(2021)

nasal CPAP device

Life-support/Therapeutic

IIb

Neonates

Feingold, B

(2010)

Implantable cardioverter-defibrillators

Life-support/Therapeutic

III

Infants, children and adolescents

Neves, L

(2021)

wide-field imaging + indirect binocular ophthalmoscopy

Diagnostics

Iia

preterms

  1. CPAP– Continuous Positive Airway Pressure; CT– Computer Tomography; ECMO– Extracorporeal Membrane Oxygenation; MRI– Magnetic Resonance Imaging; VNS– Vagus Nerve Stimulation; XR– X-ray equipment. Targeted pediatric age group according to EU regulations: neonates (preterm and term– 0 to 27 days); infants (28 days to 23 months), children (2 to 11 years) and adolescents (12 to 18 years, inclusive)